# Testosterone Therapy Effects Adipose Distribution in Older Females Post Hip-Fracture: The STEP-HI Study

**Authors:** Jacob Earp, Shangshu Zhao, Furong Xu, Richard Fortinsky, Jenna Bartley, Chia-Ling Kuo, George Kuchel

PMC · DOI: 10.1093/geroni/igaf122.4021 · 2025-12-31

## TL;DR

This study found that testosterone therapy may help prevent unhealthy fat redistribution in older women recovering from hip fractures, though it did not reduce overall fat.

## Contribution

The study is the first to investigate testosterone's effect on adipose redistribution in older women post-hip fracture.

## Key findings

- Testosterone therapy did not significantly reduce total adipose tissue compared to exercise alone.
- Testosterone therapy helped prevent the redistribution of fat into the visceral region.
- Visceral adipose tissue percentage improved significantly in the testosterone group.

## Abstract

With aging and injury females experience ectopic redistribution of appendicular adipose tissue (AAT) into the viscera, where visceral adipose tissue (VAT) becomes highly inflammatory and metabolically stressful. This adipose redistribution increases the risk of both reinjury and obesity-related illnesses. Strategies that can disrupt this unhealthy adipose redistribution after hip fracture injury (HF) are of great interest. We aimed to determine how testosterone therapy affects the amount and distribution of total adipose tissue (TAT) in older women following HF. This was a secondary analysis of the STEP-HI study, a multi-site randomized clinical trial that randomized older females recovering from HF to a 6-month resistance exercise intervention while taking either testosterone (EX+T, n = 35, age=79±9 years) or a placebo (EX+P, n = 31, age=76±7 years). Changes in TAT, AAT and VAT mass and percentage of TAT in each region (AAT% and VAT%) were measured using dual x-ray absorptiometry and compared between groups. No significant differences were observed between groups at baseline (p > 0.05). Over the intervention period, mean change between baseline and six months were not significantly different between groups for TAT (EX+P: 298±2002 g, EX+T: 419±2086 g, p = 0.827), AAT (EX+P: 52±1007 g, EX+T: 39±1078 g, p = 0.890) AAT% (EX+P: -0.42±1.40, EX+T: -0.52±1.67%, p = 0.718) and VAT (EX+P: 45±232 g, EX+T: -44±151 g, p = 0.091), while VAT% improved in the EX+T (-0.26±0.51%) compared to EX+P (+0.12±0.52%, p = 0.003). These results demonstrate that while testosterone treatment was unable to decrease overall adipose stores compared to exercise alone in older women recovering from HF, it may help prevent unhealthy adipose redistribution.

## Linked entities

- **Chemicals:** testosterone (PubChem CID 6013)
- **Diseases:** hip fracture (MONDO:0005327)

---
Source: https://tomesphere.com/paper/PMC12761648